Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
暂无分享,去创建一个
G. Descamps | M. Amiot | P. Moreau | C. Touzeau | L. Maillet | S. Maiga | C. Bellanger | C. Seiller | Charlotte Kervoëlen | P. Gomez‐Bougie | C. Pellat‐Deceunynck | C. Pellat-Deceunynck